Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases

Bruce A. Bunnell, Weiwen Deng, Christine M. Robinson, Paul R. Waldron, Trinity Bivalacqua, Syed R. Baber, Albert L. Hyman, Philip J. Kadowitz

Research output: Contribution to journalArticle

Abstract

Stem cells isolated from various sources have been shown to vary in their differentiation capacity or pluripotentiality. Two groups of stem cells, embryonic and adult stem cells, may be capable of differentiating into any desired tissue or cell type, which offers hope for the development of therapeutic applications for a large number of disorders. However, major limitations with the use of embryonic stem cells for human disease have led researchers to focus on adult stem cells as therapeutic agents. Investigators have begun to examine postnatal sources of pluripotent stem cells, such as bone marrow stroma or adipose tissue, as sources of mesenchymal stem cells. The following review focuses on recent research on the use of stem cells for the treatment of cardiovascular and pulmonary diseases and the future application of mesenchymal stem cells for the treatment of a variety of cardiovascular disorders.

Original languageEnglish (US)
Pages (from-to)529-539
Number of pages11
JournalCanadian Journal of Physiology and Pharmacology
Volume83
Issue number7
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Adult Stem Cells
Cardiovascular Diseases
Stem Cells
Research Personnel
Pluripotent Stem Cells
Embryonic Stem Cells
Lung Diseases
Adipose Tissue
Bone Marrow
Therapeutics
Research

Keywords

  • CGRP
  • eNOS
  • Gene therapy
  • Stem cells

ASJC Scopus subject areas

  • Physiology
  • Pharmacology

Cite this

Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. / Bunnell, Bruce A.; Deng, Weiwen; Robinson, Christine M.; Waldron, Paul R.; Bivalacqua, Trinity; Baber, Syed R.; Hyman, Albert L.; Kadowitz, Philip J.

In: Canadian Journal of Physiology and Pharmacology, Vol. 83, No. 7, 07.2005, p. 529-539.

Research output: Contribution to journalArticle

Bunnell, BA, Deng, W, Robinson, CM, Waldron, PR, Bivalacqua, T, Baber, SR, Hyman, AL & Kadowitz, PJ 2005, 'Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases', Canadian Journal of Physiology and Pharmacology, vol. 83, no. 7, pp. 529-539. https://doi.org/10.1139/y05-043
Bunnell, Bruce A. ; Deng, Weiwen ; Robinson, Christine M. ; Waldron, Paul R. ; Bivalacqua, Trinity ; Baber, Syed R. ; Hyman, Albert L. ; Kadowitz, Philip J. / Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases. In: Canadian Journal of Physiology and Pharmacology. 2005 ; Vol. 83, No. 7. pp. 529-539.
@article{65af9968253544618f384c4f8db29141,
title = "Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases",
abstract = "Stem cells isolated from various sources have been shown to vary in their differentiation capacity or pluripotentiality. Two groups of stem cells, embryonic and adult stem cells, may be capable of differentiating into any desired tissue or cell type, which offers hope for the development of therapeutic applications for a large number of disorders. However, major limitations with the use of embryonic stem cells for human disease have led researchers to focus on adult stem cells as therapeutic agents. Investigators have begun to examine postnatal sources of pluripotent stem cells, such as bone marrow stroma or adipose tissue, as sources of mesenchymal stem cells. The following review focuses on recent research on the use of stem cells for the treatment of cardiovascular and pulmonary diseases and the future application of mesenchymal stem cells for the treatment of a variety of cardiovascular disorders.",
keywords = "CGRP, eNOS, Gene therapy, Stem cells",
author = "Bunnell, {Bruce A.} and Weiwen Deng and Robinson, {Christine M.} and Waldron, {Paul R.} and Trinity Bivalacqua and Baber, {Syed R.} and Hyman, {Albert L.} and Kadowitz, {Philip J.}",
year = "2005",
month = "7",
doi = "10.1139/y05-043",
language = "English (US)",
volume = "83",
pages = "529--539",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "7",

}

TY - JOUR

T1 - Potential application for mesenchymal stem cells in the treatment of cardiovascular diseases

AU - Bunnell, Bruce A.

AU - Deng, Weiwen

AU - Robinson, Christine M.

AU - Waldron, Paul R.

AU - Bivalacqua, Trinity

AU - Baber, Syed R.

AU - Hyman, Albert L.

AU - Kadowitz, Philip J.

PY - 2005/7

Y1 - 2005/7

N2 - Stem cells isolated from various sources have been shown to vary in their differentiation capacity or pluripotentiality. Two groups of stem cells, embryonic and adult stem cells, may be capable of differentiating into any desired tissue or cell type, which offers hope for the development of therapeutic applications for a large number of disorders. However, major limitations with the use of embryonic stem cells for human disease have led researchers to focus on adult stem cells as therapeutic agents. Investigators have begun to examine postnatal sources of pluripotent stem cells, such as bone marrow stroma or adipose tissue, as sources of mesenchymal stem cells. The following review focuses on recent research on the use of stem cells for the treatment of cardiovascular and pulmonary diseases and the future application of mesenchymal stem cells for the treatment of a variety of cardiovascular disorders.

AB - Stem cells isolated from various sources have been shown to vary in their differentiation capacity or pluripotentiality. Two groups of stem cells, embryonic and adult stem cells, may be capable of differentiating into any desired tissue or cell type, which offers hope for the development of therapeutic applications for a large number of disorders. However, major limitations with the use of embryonic stem cells for human disease have led researchers to focus on adult stem cells as therapeutic agents. Investigators have begun to examine postnatal sources of pluripotent stem cells, such as bone marrow stroma or adipose tissue, as sources of mesenchymal stem cells. The following review focuses on recent research on the use of stem cells for the treatment of cardiovascular and pulmonary diseases and the future application of mesenchymal stem cells for the treatment of a variety of cardiovascular disorders.

KW - CGRP

KW - eNOS

KW - Gene therapy

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=27744573156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744573156&partnerID=8YFLogxK

U2 - 10.1139/y05-043

DO - 10.1139/y05-043

M3 - Article

VL - 83

SP - 529

EP - 539

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 7

ER -